Clinical Trial Update: GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating GPC3 CAR T cells with IL-15 and IL-21 for recurrent atypical teratoid rhabdoid tumor and CNS rhabdoid tumors; currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Central Nervous System Rhabdoid Tumor

Drugs mentioned

• GPC3 CAR T Cells with IL-15 and IL-21

Snippet

Sponsor: Baylor College of Medicine | Conditions: Atypical Teratoid Rhabdoid Tumor, Central Nervous System Rhabdoid Tumor | Phase 1 | Status: NOT_YET_RECRUITING